Sign In
Buy VERA
$31.58
-1.31 (-3.98%)
At Close: Aug 10, 2026
Vera Therapeutics to Participate at Upcoming Investor Conferences
08:00am, Tuesday, 24'th Feb 2026
BRISBANE, Calif., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company focused on developing and commercializing transformative treatme
Vera Therapeutics: Hold Rating Based On Potential For Atacicept In IgAN (Rating Downgrade)
04:00pm, Friday, 20'th Feb 2026
Vera Therapeutics is downgraded from 'Strong Buy' to 'Hold' due to intensifying competition in the IgAN space. VERA's atacicept met the primary endpoint in the phase 3 ORIGIN trial, enabling a BLA sub
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:05pm, Friday, 06'th Feb 2026
BRISBANE, Calif., Feb. 06, 2026 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that, on February 2, 2026, the Compensation Committee of the Board of Directors (Compensation
Comparing Vera Therapeutics (NASDAQ:VERA) & Inventiva (NASDAQ:IVA)
01:18am, Thursday, 05'th Feb 2026
Inventiva (NASDAQ: IVA - Get Free Report) and Vera Therapeutics (NASDAQ: VERA - Get Free Report) are both medical companies, but which is the better stock? We will compare the two companies based on t
Vera Therapeutics Announces Appointment of Matt Skelton to Chief Commercial Officer
07:30am, Wednesday, 28'th Jan 2026
BRISBANE, Calif., Jan. 28, 2026 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company focused on developing and commercializing transformative treatme
SG Americas Securities LLC Takes $911,000 Position in Vera Therapeutics, Inc. $VERA
06:23am, Tuesday, 20'th Jan 2026
SG Americas Securities LLC acquired a new stake in shares of Vera Therapeutics, Inc. (NASDAQ: VERA) in the third quarter, according to the company in its most recent disclosure with the Securities and
Wall Street Analysts See a 53.05% Upside in Vera Therapeutics (VERA): Can the Stock Really Move This High?
10:55am, Wednesday, 14'th Jan 2026
The consensus price target hints at a 53.1% upside potential for Vera Therapeutics (VERA). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings
Vera Therapeutics, Inc. (VERA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
08:15pm, Tuesday, 13'th Jan 2026
Vera Therapeutics, Inc. (VERA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01:05pm, Friday, 09'th Jan 2026
BRISBANE, Calif., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that, on January 5, 2026, the Compensation Committee of the Board of Directors of Vera Therap
Why Vera Therapeutics Stock Zoomed Higher Today
07:21pm, Wednesday, 07'th Jan 2026
The biotech has formally submitted a biologics license application to the FDA for its kidney disease drug. It has been accepted for priority review by the healthcare industry regulator.
FDA Fast-Tracks Vera's At-Home Kidney Drug
12:29pm, Wednesday, 07'th Jan 2026
Vera Therapeutics Inc. (NASDAQ: VERA) stock rose Wednesday after the U.S. Food and Drug Administration (FDA) accepted the company's atacicept Biologics License Application (BLA) for Priority Review.
Vera Therapeutics Announces U.S. FDA Granted Priority Review to Biologics License Application for Atacicept for Treatment of Adults with IgA Nephropathy
Wells Fargo sees short squeeze ahead: here are three stocks to play it
02:31pm, Tuesday, 06'th Jan 2026
Wells Fargo analysts believe a combination of tax refund spending, stronger earnings in lagging sectors, and fresh liquidity from the Federal Reserve could spark a “reflation” in equities. In a no
Patrick Enright Purchases 5,882 Shares of Vera Therapeutics (NASDAQ:VERA) Stock
05:26am, Wednesday, 17'th Dec 2025
Vera Therapeutics, Inc. (NASDAQ: VERA - Get Free Report) Director Patrick Enright acquired 5,882 shares of the stock in a transaction dated Thursday, December 11th. The shares were purchased at an ave
Vera Therapeutics Announces Pricing of Public Offering of Class A Common Stock
08:57pm, Tuesday, 09'th Dec 2025
BRISBANE, Calif., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (“Vera Therapeutics”), a late clinical-stage biotechnology company focused on developing and commercializing transformat
